BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3558750)

  • 1. Wechsler Intelligence Scale profiles, the cholinergic system, and Alzheimer's disease.
    Filley CM; Kobayashi J; Heaton RK
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):180-6. PubMed ID: 3558750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cholinergic deficiency WAIS profiles in a nondemented aged sample.
    Tuokko H; Crockett D
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):225-7. PubMed ID: 3558752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAIS-R subtest profile and cortical perfusion in Alzheimer's disease.
    Alexander GE; Prohovnik I; Stern Y; Mayeux R
    Brain Cogn; 1994 Jan; 24(1):24-43. PubMed ID: 8123262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of the WAIS-R Fuld profile in HIV-1 infection.
    van Gorp WG; Tulin SJ; Evans G; Satz P
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):807-11. PubMed ID: 2258439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the diagnostic utility of the Fuld cholinergic deficit profile on the Japanese WAIS-R.
    Yamashita H; Hirono N; Ikeda M; Ikejiri Y; Imamura T; Shimomura T; Mori E
    J Clin Exp Neuropsychol; 1997 Apr; 19(2):300-4. PubMed ID: 9240488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of dementia patients by a WAIS profile related to central cholinergic deficiencies.
    Brinkman SD; Braun P
    J Clin Neuropsychol; 1984 Nov; 6(4):393-400. PubMed ID: 6501580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuld's formula and WAIS subtests in differential diagnosis of dementia.
    Caffarra P; Scaglioni A; Malvezzi L; Girotti F; Soliveri P; Musicco M; Previdi P
    Funct Neurol; 1991; 6(1):23-7. PubMed ID: 2055547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing between vascular dementia and Alzheimer's disease by means of the WAIS: a meta-analysis.
    Oosterman JM; Scherder EJ
    J Clin Exp Neuropsychol; 2006 Oct; 28(7):1158-75. PubMed ID: 16840242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal sensitivity of the Fuld cholinergic profile to Alzheimer's disease.
    Goldman RS; Axelrod BN; Giordani BJ; Foster N; Berent S
    J Clin Exp Neuropsychol; 1992 Jul; 14(4):566-74. PubMed ID: 1400919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
    Satz P; Hynd GW; D'Elia L; Daniel MH; Van Gorp W; Connor R
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):759-65. PubMed ID: 2258435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WAIS-R profile: a diagnostic tool for Alzheimer's disease?
    Logsdon RG; Teri L; Williams DE; Vitiello MV; Prinz PN
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):892-8. PubMed ID: 2592529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.
    Satz P; Van Gorp WG; Soper HV; Mitrushina M
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):767-74. PubMed ID: 3693533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of brief intelligence tests for patients with Alzheimer's disease.
    Nakamura H; Nakanishi M; Furukawa TA; Hamanaka T; Tokudome S
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):435-9. PubMed ID: 10997860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of intellectual function in dementing disorders: validity of WAIS-R short forms for patients with Alzheimer's, Huntington's, and Parkinson's disease.
    Randolph C; Mohr E; Chase TN
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):743-53. PubMed ID: 8276933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wechsler Adult Intelligence Scale-III profile in the early stages of Alzheimer's disease: performance in subtests sensitive to and resistant to normal decline with ageing.
    Matsuda O; Saito M; Kato M; Azami H; Shido E
    Psychogeriatrics; 2015 Mar; 15(1):1-6. PubMed ID: 25515267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuropsychological profile in dementia with Lewy bodies and Alzheimer's disease.
    Oda H; Yamamoto Y; Maeda K
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):125-31. PubMed ID: 18615776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale-Third Edition support earlier findings.
    Hawkins KA
    J Psychiatry Neurosci; 1999 Sep; 24(4):341-7. PubMed ID: 10516802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAIS-R intersubtest scatter in patients with dementia of Alzheimer's type.
    Mitrushina M; Drebing C; Satz P; Van Gorp W; Chervinsky A; Uchiyama C
    J Clin Psychol; 1994 Sep; 50(5):753-8. PubMed ID: 7806653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Education and cognitive function in Alzheimer's disease.
    Filley CM; Cullum CM
    Neuropsychiatry Neuropsychol Behav Neurol; 1997 Jan; 10(1):48-51. PubMed ID: 9118196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.